Insider Trading & Ownership - Nassif David W.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Nassif David W.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-02-08
Option Award
2022-02-10
5:05 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Interim CEO, CFO
546,500$0546,500
(Direct)
View
2021-12-08
Tax Withholding
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
6,294$1.4280,310
(Direct)
View
2021-12-08
Disposition
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
17,534$080,310
(Direct)
View
2021-12-08
Option Award
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
17,534$080,310
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:53 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
239,000$0239,000
(Direct)
View
2021-03-22
Disposition
2021-03-22
9:25 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
15,060$034,004
(Direct)
View
2021-03-22
Option Award
2021-03-22
9:25 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
15,060$034,004
(Direct)
View
2020-06-11
Tax Withholding
2020-06-15
7:40 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
5,266$3.2534,004
(Direct)
View
2020-06-12
Disposition
2020-06-15
7:40 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
15,060$034,004
(Direct)
View
2020-06-11
Option Award
2020-06-15
7:40 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
15,060$034,004
(Direct)
View
2020-04-15
Option Award
2020-04-17
9:01 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
131,500$0131,500
(Direct)
View